Post-earnings recap
Reported
Thu, May 7, 2026
EPS actual
$1.76
EPS est.
$1.23
EPS surprise
+43.09%
1-day move
+7.72%
—
Est. EPS
$1.57
Est. Rev
$464M
Impl. Move
±7.2%
Collegium Pharmaceutical reported strong earnings with an EPS of $1.76, significantly exceeding expectations. The positive surprise likely contributed to the stock's increase of 7.72% following the earnings announcement. However, without revenue data or management commentary, investors may need to wait for further details to assess the company's overall performance and outlook.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.76 | N/A | +43.09% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based solely on numerical results.